APA (7th ed.) Citation

XY, J., DJ, L., SN, S., QK, D., SW, S., L, H., . . . XX, L. (2025). Effective treatment with daratumumab in post-HSCT refractory immune-mediated cytopenias: A case report and literature review. Frontiers in immunology, 16, 1625365. https://doi.org/10.3389/fimmu.2025.1625365

Chicago Style (17th ed.) Citation

XY, Jing, et al. "Effective Treatment with Daratumumab in Post-HSCT Refractory Immune-mediated Cytopenias: A Case Report and Literature Review." Frontiers in Immunology 16 (2025): 1625365. https://doi.org/10.3389/fimmu.2025.1625365.

MLA (9th ed.) Citation

XY, Jing, et al. "Effective Treatment with Daratumumab in Post-HSCT Refractory Immune-mediated Cytopenias: A Case Report and Literature Review." Frontiers in Immunology, vol. 16, 2025, p. 1625365, https://doi.org/10.3389/fimmu.2025.1625365.